94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
REVIEW article
Oncol. Rev.
Sec. Oncology Reviews: Reviews
Volume 19 - 2025 | doi: 10.3389/or.2025.1446850
This article is part of the Research Topic Update on the Diagnosis and Surgical Treatment of Gynecological Tumors View all 7 articles
Ultrasound in endometrial cancer:evaluating the impact of pre-surgicalstaging
Provisionally accepted- 1 IPO-Porto Research Centre, Portuguese Oncology Institute, Porto, Portugal
- 2 Department of Gynecology-Obstetrics and Pediatrics, Faculty of Medicine, University of Porto, Porto, Portugal
- 3 Other, Porto, Portugal
Preoperative staging in endometrial cancer has recently been implied as an important contribution to an accurate selection of low-risk cases, ultimately avoiding unnecessary lymph node debulking. Transvaginal ultrasound seems promising in clinical staging, as it offers the possibility to assess the depth of myometrial infiltration and cervical stromal invasion. This is a commonly available, non-invasive and low-cost modality, standing as an accurate alternative to MRI, especially in medium and low-income countries, where MRI is not promptly available and costs are an important issue.This review aims to summarize the progressive role of clinical implementation of pelvic ultrasonography in the locoregional staging of endometrial carcinoma and to compare its accuracy with other preoperative methods.
Keywords: Endometrial neoplasia, Uterine Cancer, Pelvic ultrasound, Myometrial invasion, Cervical invasion, Staging & surgical approach
Received: 10 Jun 2024; Accepted: 14 Feb 2025.
Copyright: © 2025 Rei, Bernardes and Costa. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Mariana Rei, IPO-Porto Research Centre, Portuguese Oncology Institute, Porto, Portugal
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.